pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 368 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
(brimonidine tartrate + timolol maleate)
Brimonidine Tartrate + Timolol Maleate ((brimonidine tartrate + timolol maleate))
Glaucoma
Sentiss Pharmaceuticals LLC
0 catalysts
Marketed
(cyclopentolate hydrochloride + phenylephrine hydrochloride)
Cyclomydril ((cyclopentolate hydrochloride + phenylephrine hydrochloride))
Mydriasis
$ALCALCON INC
0 catalysts
Marketed
(dexamethasone + tobramycin)
Tobradex ST ((dexamethasone + tobramycin))
Ocular Inflammation
$HROWHARROW, INC.
catalysts
← prev
page 3 of 13
next →
131
Pain89
Neurology1
0
Marketed
(dextromethorphan + promethazine)
Promethazine DM ((dextromethorphan [INN] + promethazine [INN]))
Nasopharyngitis (Common Cold)
PAI Holding Co LLC
0 catalysts
Phase 2
(difluprednate + povidone iodine)
(difluprednate + povidone iodine [USP])
Viral Conjunctivitis
iView Therapeutics Inc
0 catalysts
Marketed
(gramicidin + neomycin sulfate + polymyxin B)
Neomycin + Polymyxin B Sulfates + Gramicidin ((gramicidin [INN] + neomycin sulfate + polymyxin B [INN]))
Bacterial Conjunctivitis
Sciegen Pharmaceuticals Inc
0 catalysts
Marketed
(hydrocortisone + neomycin sulfate + polymyxin B)
Casporyn HC ((hydrocortisone [INN] + neomycin sulfate + polymyxin B [INN]))
Otitis Externa
Casper Pharma LLC
0 catalysts
Marketed
(ketorolac tromethamine + phenylephrine hydrochloride)
Ketorolac Tromethamine + Phenylephrine Hydrochloride ((ketorolac tromethamine + phenylephrine hydrochloride))
Ocular Pain (Eye Pain)
Lupin Ltd
0 catalysts
Marketed
(latanoprost + netarsudil mesylate)
Rocklatan ((latanoprost + netarsudil mesylate))
Ocular Hypertension
$ALCALCON INC
0 catalysts
Marketed
(naphazoline + pheniramine maleate)
Naphazoline Hydrochloride + Pheniramine Maleate ((naphazoline [INN] + pheniramine maleate))
Allergic Conjunctivitis
Altaire Pharmaceuticals Inc
0 catalysts
Phase 3
(neltependocel + Y-27632)
Vyznova (neltependocel [INN])
Corneal Edema
Aurion Biotech Inc
0 catalysts
Marketed
(polymyxin B + trimethoprim sulfate)
Polymyxin B + Trimethoprim Sulfate Pacific ((polymyxin B [INN] + trimethoprim sulfate))
Bacterial Conjunctivitis
Pacific Pharmaceuticals USA
0 catalysts
Marketed
(prednisolone sodium phosphate + sulfacetamide sodium)
Sulfacetamide Sodium + Prednisolone Sodium Phosphate ((prednisolone sodium phosphate + sulfacetamide sodium))
Anterior Uveitis
Bausch Health US LLC
0 catalysts
Phase 3
(riboflavin + sodium iodide)
(riboflavin [INN] + sodium iodide [USP])
Keratoconus
Epion Therapeutics Inc
0 catalysts
Preclinical
(rifampin + polymyxin B + trimethoprim)
(rifampin + polymyxin B [INN] + trimethoprim)
Bacterial Keratitis
University of Rochester
0 catalysts
Phase 3
4D-150
Wet (Neovascular / Exudative) Macular Degeneration
$FDMT4D Molecular Therapeutics, Inc.
0 catalysts
Preclinical
6SP-2407
Macular Degeneration
6S Pharma LLC
0 catalysts
Phase 2
A-197
Keratoconjunctivitis Sicca (Dry Eye)
Aramis Biosciences Inc
0 catalysts
Preclinical
AAV-RDH12
$MGTXMeiraGTx Holdings plc
0 catalysts
Phase 2
AAVB-039
Juvenile Macular Degeneration (Stargardt Disease)
AAVantgarde Bio Srl
0 catalysts
Phase 2
ABI-110
Polypoidal Choroidal Vasculopathy
Avirmax Inc
0 catalysts
Preclinical
ABO-503
Retinal Degeneration
$ABEOABEONA THERAPEUTICS INC.
0 catalysts
Preclinical
ABO-504
Juvenile Macular Degeneration (Stargardt Disease)
$ABEOABEONA THERAPEUTICS INC.
0 catalysts
Preclinical
ABO-505
Optic Neuropathy
$ABEOABEONA THERAPEUTICS INC.
0 catalysts
Phase 2
ACDN-01
Juvenile Macular Degeneration (Stargardt Disease)
Ascidian Therapeutics Inc
0 catalysts
Preclinical
AChE Inhibitors
Acne Vulgaris
Attillaps Holdings Inc
0 catalysts
Preclinical
AG-73305
Retinal Vein Occlusion
Allgenesis Biotherapeutics Inc
0 catalysts
Preclinical
AGN-001
Retinitis Pigmentosa (Retinitis)
Agnos Therapeutics Inc
0 catalysts
Preclinical
AMP-107
Diabetic Macular Edema
$AMPHAmphastar Pharmaceuticals, Inc.
0 catalysts
Phase 2
ANXV
Retinal Vein Occlusion
Annexin Pharmaceuticals AB
0 catalysts